Clinical Trials in North Carolina

Showing 16381-16400 of 19,028 trials

Dose Finding Study In Subjects With Crow's Feet

NCT01951742

The purpose of this study is to establish the therapeutic range of ANT-1401 in the treatment of Crow's Feet.

Anterios Inc.145 participantsStarted Sep 2013

Miami, Florida, United States • Pinellas Park, Florida, United States • West Palm Beach, Florida, United States +7 more locations

COMPLETED31 miles

Deplin® P.L.U.S. Program (Progress Through Learning Understanding & Support)

NCT01369030

This study will be an observational study in which patients who have been prescribed Deplin® are invited to participate in surveys regarding their experiences with Deplin®. The purpose of this study is to increase the understanding of the role of L-methylfolate among patients who are candidates for Deplin®, provide patients with personalized education and support, and contribute to the overall understanding of the needs and concerns of patients being treated for depression.

Major Depressive Disorder

Pamlab, Inc.554 participantsStarted Nov 2010

Greensboro, North Carolina, United States • Nashville, Tennessee, United States

COMPLETEDPhase 331 miles

A Trial of Degarelix in Patients With Prostate Cancer

NCT00946920

A phase 3, open-label, parallel group, one year trial comparing the efficacy and safety of degarelix 3-month depot with the established therapy goserelin acetate 3-month implant in patients with prostate cancer.

Prostate Cancer

Ferring Pharmaceuticals859 participantsStarted Jun 2009

Homewood, Alabama, United States • Little Rock, Arkansas, United States • Fresno, California, United States +123 more locations

Dose Finding Study In Subjects With Crow's Feet

Deplin® P.L.U.S. Program (Progress Through Learning Understanding & Support)

A Trial of Degarelix in Patients With Prostate Cancer

Find Trials by Condition in North Carolina

An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men

VX-950-C211 - A Dosing Regimen Study (Twice Daily Versus Every 8 Hours) of Telaprevir in Treatment-naïve Participants With Genotype 1 Chronic Hepatitis C Virus Infection

Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma

Selumetinib in Treating Patients With Locally Advanced or Metastatic Liver Cancer

Safety of Urate Elevation in Parkinson's Disease

Sofosbuvir With Pegylated Interferon and Ribavirin Hepatitis C Virus (HCV) Genotypes 1,4,5,6

Trial Evaluating the Safety and Effectiveness of NUBAC™ Disc Arthroplasty

Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer

Safety and Efficacy of AST-120 Compared to Lactulose in Patients With Hepatic Encephalopathy

Computed Tomography Dose Reduction Using Sequential or Fast Pitch Sprial Technique

An Efficacy and Safety Study of One Dosage of Paliperidone Extended Release (ER) in Treating Patients With Schizophrenia

Vorinostat and Trastuzumab in Treating Patients With Metastatic or Locally Recurrent Breast Cancer

Pazopanib in Treating Patients With Metastatic Urothelial Cancer

Carboplatin, Paclitaxel, and Bevacizumab With or Without Erlotinib Hydrochloride in Treating Non-Smokers With Advanced Non-Small Cell Lung Cancer

Growth and Tolerance of Infants Fed Infant Formulas

Inhaled Iloprost for the Treatment of Persistent Pulmonary Hypertension in the Term and Near Term Infants.

Evaluation of Monthly Darbepoetin Alfa Dosing for Correction of Anemia in Non-dialysis Chronic Kidney Disease